HCAT - Health Catalyst, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
South Jordan,
United States
Type: Equity
HCAT price evolution
HCAT
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $106.28 | $94.97 | $115.69 | $133.48 |
| Short term investments | $211.45 | $252.73 | $228.14 | $223.45 |
| Net receivables | $60.29 | $46.09 | $52.38 | $61.86 |
| Inventory | ||||
| Total current assets | $393.4 | $408.45 | $410.95 | $434.52 |
| Long term investments | ||||
| Property, plant & equipment | $39.64 | $41.37 | $41.85 | $42.6 |
| Goodwill & intangible assets | $264.04 | $257.98 | $265.02 | $270.39 |
| Total noncurrent assets | $308.42 | $304.47 | $311.95 | $317.78 |
| Total investments | $211.45 | $252.73 | $228.14 | $223.45 |
| Total assets | $701.81 | $712.92 | $722.9 | $752.3 |
| Current liabilities | ||||
| Accounts payable | $6.64 | $6.33 | $7.97 | $9.24 |
| Deferred revenue | $55.83 | $53.38 | $59.62 | $66.09 |
| Short long term debt | $3.36 | $3.4 | $3.47 | $3.39 |
| Total current liabilities | $89.03 | $84.25 | $86.76 | $102.5 |
| Long term debt | $245.71 | $245.89 | $246.06 | $244.35 |
| Total noncurrent liabilities | $245.86 | $246.27 | $246.28 | $244.66 |
| Total debt | $249.07 | $249.29 | $249.53 | $247.74 |
| Total liabilities | $334.89 | $330.53 | $333.04 | $347.15 |
| Shareholders' equity | ||||
| Retained earnings | -$1117.17 | -$1086.86 | -$1064.83 | -$1032.21 |
| Other shareholder equity | $0.03 | -$0.17 | -$0.2 | -$0.29 |
| Total shareholder equity | $366.92 | $382.39 | $389.87 | $405.15 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $106.28 | $116.31 | $193.23 | $91.95 |
| Short term investments | $211.45 | $247.18 | $251.75 | $178.92 |
| Net receivables | $60.29 | $47.97 | $48.8 | $48.3 |
| Inventory | ||||
| Total current assets | $393.4 | $427.8 | $508.39 | $329.8 |
| Long term investments | ||||
| Property, plant & equipment | $39.64 | $42.59 | $44.45 | $37.59 |
| Goodwill & intangible assets | $264.04 | $278.17 | $274.76 | $206.74 |
| Total noncurrent assets | $308.42 | $324.49 | $323.7 | $247.94 |
| Total investments | $211.45 | $247.18 | $251.75 | $178.92 |
| Total assets | $701.81 | $752.29 | $832.1 | $577.74 |
| Current liabilities | ||||
| Accounts payable | $6.64 | $4.42 | $4.69 | $5.33 |
| Deferred revenue | $55.83 | $55.07 | $57.56 | $49.02 |
| Short long term debt | $3.36 | $3.43 | $3.42 | $2.62 |
| Total current liabilities | $89.03 | $82.51 | $93.05 | $88.04 |
| Long term debt | $245.71 | $226.52 | $201.19 | $192.66 |
| Total noncurrent liabilities | $245.86 | $244.77 | $216.95 | $213.6 |
| Total debt | $249.07 | $247.97 | $204.61 | $195.28 |
| Total liabilities | $334.89 | $327.28 | $310 | $301.64 |
| Shareholders' equity | ||||
| Retained earnings | -$1117.17 | -$999.02 | -$878.86 | -$725.65 |
| Other shareholder equity | $0.03 | -$0.65 | -$0.07 | $0.06 |
| Total shareholder equity | $366.92 | $425.01 | $522.1 | $276.1 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $75.08 | $73.77 | $73.21 | $73.87 |
| Cost of revenue | $44.58 | $41.79 | $39.44 | $38.3 |
| Gross Profit | $30.51 | $31.99 | $33.77 | $35.56 |
| Operating activities | ||||
| Research & development | $20.29 | $17.67 | $17.59 | $17.08 |
| Selling, general & administrative | $32.7 | $28.71 | $40.07 | $42.4 |
| Total operating expenses | $63.29 | $56.57 | $68.39 | $70.48 |
| Operating income | -$32.78 | -$24.58 | -$34.62 | -$34.91 |
| Income from continuing operations | ||||
| EBIT | -$32.78 | -$24.58 | -$34.62 | -$34.91 |
| Income tax expense | $0.14 | $0.06 | $0.09 | $0.07 |
| Interest expense | -$2.62 | -$2.61 | -$2.09 | -$1.79 |
| Net income | ||||
| Net income | -$30.31 | -$22.03 | -$32.61 | -$33.19 |
| Income (for common shares) | -$30.31 | -$22.03 | -$32.61 | -$33.19 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $295.94 | $276.24 | $241.93 | $188.84 |
| Cost of revenue | $164.1 | $143.05 | $124.35 | $98.08 |
| Gross Profit | $131.83 | $133.19 | $117.57 | $90.77 |
| Operating activities | ||||
| Research & development | $72.63 | $75.68 | $62.73 | $53.52 |
| Selling, general & administrative | $143.88 | $149.22 | $160.96 | $114.65 |
| Total operating expenses | $258.73 | $273.19 | $261.22 | $186.89 |
| Operating income | -$126.9 | -$140 | -$143.65 | -$96.13 |
| Income from continuing operations | ||||
| EBIT | -$126.9 | -$140 | -$143.65 | -$104.64 |
| Income tax expense | $0.36 | -$4.28 | -$6.9 | -$1.19 |
| Interest expense | -$9.11 | $1.68 | $16.46 | $11.57 |
| Net income | ||||
| Net income | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| Income (for common shares) | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$30.31 | -$22.03 | -$32.61 | -$33.19 |
| Operating activities | ||||
| Depreciation | $11.02 | $10.93 | $11.51 | $11.76 |
| Business acquisitions & disposals | -$11.39 | |||
| Stock-based compensation | $13.01 | $14.23 | $14.63 | $13.88 |
| Total cash flows from operations | -$19.04 | $3.12 | -$11.57 | -$5.58 |
| Investing activities | ||||
| Capital expenditures | -$2.87 | -$3.08 | -$3.93 | -$3.28 |
| Investments | $44.31 | -$21.76 | -$2.62 | $26.03 |
| Total cash flows from investing | $29.92 | -$24.86 | -$7.42 | $22.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.4 | $1.04 | $1.2 | $0.09 |
| Net borrowings | ||||
| Total cash flows from financing | $0.4 | $1.04 | $1.2 | $0.09 |
| Effect of exchange rate | $0.03 | -$0.01 | -$0 | $0.01 |
| Change in cash and equivalents | $11.3 | -$20.72 | -$17.79 | $17.17 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$118.15 | -$137.4 | -$153.21 | -$115.02 |
| Operating activities | ||||
| Depreciation | $45.21 | $51.53 | $41.11 | $23.03 |
| Business acquisitions & disposals | -$11.39 | -$27.85 | -$46.76 | -$101.66 |
| Stock-based compensation | $55.76 | $72.1 | $65.14 | $37.96 |
| Total cash flows from operations | -$33.08 | -$35.27 | -$23.12 | -$26.15 |
| Investing activities | ||||
| Capital expenditures | -$13.16 | -$15.13 | -$17.07 | -$9.2 |
| Investments | $45.97 | $6.21 | -$74.47 | $29.54 |
| Total cash flows from investing | $20.29 | -$39.02 | -$139.68 | -$82.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.73 | -$1.27 | $270.37 | $40.54 |
| Net borrowings | $143.7 | |||
| Total cash flows from financing | $2.73 | -$2.61 | $264.08 | $182.61 |
| Effect of exchange rate | $0.02 | -$0.01 | -$0.01 | $0.03 |
| Change in cash and equivalents | -$10.04 | -$76.92 | $101.27 | $73.92 |
News
Fundamentals
| Market cap | $325.29M |
|---|---|
| Enterprise value | $468.08M |
| Shares outstanding | 58.30M |
| Revenue | $295.94M |
|---|---|
| EBITDA | -$81.68M |
| EBIT | -$126.90M |
| Net Income | -$118.15M |
| Revenue Q/Q | 8.56% |
| Revenue Y/Y | 7.13% |
| P/E ratio | -2.75 |
|---|---|
| EV/Sales | 1.58 |
| EV/EBITDA | -5.73 |
| EV/EBIT | -3.69 |
| P/S ratio | 1.10 |
| P/B ratio | 0.89 |
| Book/Share | 6.29 |
| Cash/Share | 1.82 |
| EPS | -$2.03 |
|---|---|
| ROA | -16.35% |
| ROE | -30.60% |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | -2.80 |
| Current ratio | 4.42 |
| Quick ratio | 4.42 |